Auro Laboratories (BOM:530233) COGS-to-Revenue : 0.75 (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Auro Laboratories COGS-to-Revenue?

Auro Laboratories's Cost of Goods Sold for the three months ended in Dec. 2024 was ₹22.8 Mil. Its Revenue for the three months ended in Dec. 2024 was ₹30.5 Mil.

Auro Laboratories's COGS to Revenue for the three months ended in Dec. 2024 was 0.75.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Auro Laboratories's Gross Margin % for the three months ended in Dec. 2024 was 25.23%.

Auro Laboratories COGS-to-Revenue Historical Data

The historical data trend for Auro Laboratories's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auro Laboratories COGS-to-Revenue Chart

Auro Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.60

0.56

0.67

0.70

0.53

Auro Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial															0.54	0.50	0.30	0.02	0.75

Auro Laboratories COGS-to-Revenue Calculation

Auro Laboratories's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	277.606	/	526.996
	=	0.53

Auro Laboratories's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	22.84	/	30.547
	=	0.75

Auro Laboratories (BOM:530233) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Auro Laboratories's Gross Margin % for the three months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	22.84 / 30.547
	=	25.23 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Auro Laboratories COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Auro Laboratories's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Auro Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030

Website

http://www.aurolabs.com

Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.

Auro Laboratories Headlines

No Headlines